Content about DSN AM

ROCHESTER, N.Y. — SoloHealth founder and CEO Bart Foster has joined the Dell Innovators Credit Fund Founders Club, which computer manufacturer Dell created for what it regards as innovative business leaders, SoloHealth said.

FAIRFAX, Va. — ThinkGeek's GeekLabs on Wednesday announced the launch of four votive candles scented to evoke special memories, from a pizza arcade to a high school locker room.

"You always see candles that take you on 'exotic journeys'," staid Ty Liotta, chief of GeekLabs. "We wanted to create something more accessible. Something that every geek will relate to."

NEW YORK — Slated to hit the U.S. retail market in April is the new Neovadiol range from Vichy Laboratoires, a leading pharmacy skin care line for the signs of hormonal aging in Europe and Canada.

The new Neovadiol Gf Lip & Eye Contours and Neovadiol Lumiere BB Cream complete the range, which already includes day and night creams. The Neovadiol range was developed in consultation with experts like dermatologists, obstetricians, gynecologists and psychologists.

FORT WORTH, Texas — A topical medication made by Galderma Labs for treating melasma of the face is now available in pharmacies, Galderma said.

Tri-Luma (fluocinolone acetonide 0.01%, hydroquinone 4%), tretinoin 0.05%) is described as the only Food and Drug Administration-approved triple combination topical product for the short-term treatment of moderate to severe melasma. The chronic skin condition affects more than 7 million people in the United States.

WOODCLIFF LAKE, N.J. — I.D. Systems on Tuesday announced that Walgreens will be implementing I.D. Systems' PowerFleet wireless Vehicle Management System to help secure, track and manage high-value enterprise assets. 

CHICAGO — A mere 2% increase in the payroll tax could represent $800 in reduced spending power per year for a person with a household income of $40,000, according to a new study by SymphonyIRI.

Symphony Consulting, a division of the Chicago-based market research firm, analyzed shopper behavior since the payroll tax increased on Jan. 1, focusing on the effect of the payroll tax on food and beverage consumption, including its effect on such dimensions as stores shopped, brands purchased and the effect on various segments and categories.

PORTLAND, Maine — Putney has launched a generic version of a veterinary skin infection drug, the company said.

Putney announced the launch of cefpodoxime proxetil, a generic version of Pfizer's Simplicef, used to treat certain skin infections in dogs. Putney said its product was the only generic version of Simplicef approved by the Food and Drug Administration.

NEW YORK — GlaxoSmithKline may be looking to buy a Brazilian drug maker for up to $4 billion, according to published reports.

Reuters, citing unnamed sources, said GSK was one of several drug companies looking to buy Ache Laboratorios Farmaceuticos for $3 billion to $4 billion. Other companies looking to buy the drug maker included Novartis, Pfizer and Abbott Labs.

Reuters noted that the company was attractive to drug makers looking to expand their footprints in Latin America and that it was a major producer of prescription and OTC medications.

PLYMOUTH, Wis. — A two-time winner of "Dancing with the Stars" and a food product manufacturer have a deal to promote healthy snacking options for women.

ABBOTT PARK, Ill. — According to a national survey of fitness enthusiasts who exercise three or more times a week, 82% admitted to falling short when it comes to post-workout nutrition habits, Abbott announced Tuesday. 

The results of the survey from Abbott's EAS Sports Nutrition uncover a gap between Americans' knowledge surrounding post-workout nutrition and their desire to improve their fitness routines and results.

JERUSALEM — Teva Pharmaceutical Industries has added a University of California at Los Angeles medical professor to its board of directors, the Israeli drug maker said.

Teva announced the appointment of Arie Belldegrun, who is a director at the UCLA Institute of Urology Oncology and professor and chair of urologic oncology at the David Geffen School of Medicine. The company appointed Belldegrun at its Feb. 5 meeting to fill a vacancy, and Belldegrun's term will extend the drug maker's 2013 annual shareholder meeting.